Tokyo, Japan

Tomohiro Uetake


Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 42(Granted Patents)


Location History:

  • Tokyo 101, JP (1999)
  • Tokyo, JP (1998 - 2000)

Company Filing History:


Years Active: 1998-2000

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Tomohiro Uetake

Introduction

Tomohiro Uetake is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-ulcer and antibacterial drugs. With a total of eight patents to his name, Uetake's work has had a considerable impact on medical science.

Latest Patents

Among his latest patents are a pyrrolidine derivative and a pyridine derivative, both of which serve as anti-ulcer and antibacterial drugs. The pyrrolidine derivative is characterized by a specific formula where R1 is an alkenyl group and R2 is either a lower alkoxy group or a halogen atom. Similarly, the pyridine derivative is defined by a formula where W represents a group expressed by another specific formula, with R1 representing an alkenyloxy group and n being either 1 or 2. These innovations showcase Uetake's commitment to advancing pharmaceutical research.

Career Highlights

Throughout his career, Uetake has worked with notable companies, including Shiseido Company, Limited. His experience in the pharmaceutical industry has allowed him to develop groundbreaking solutions that address critical health issues.

Collaborations

Uetake has collaborated with esteemed colleagues such as Chikao Nishino and Fumitaka Sato. These partnerships have further enriched his research and development efforts, leading to innovative breakthroughs in drug formulation.

Conclusion

Tomohiro Uetake's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator. His work continues to influence the development of effective medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…